DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the PE ratio of Kimia Biosciences Ltd?

Kimia Biosciences Ltd has a price-to-earnings (PE) ratio of 19.4 in the Healthcare sector.

What is the market capitalisation of Kimia Biosciences Ltd?

Kimia Biosciences Ltd has a market capitalisation of approximately ₹135 crore.

Is Kimia Biosciences Ltd a profitable company?

Kimia Biosciences Ltd generates a return on equity of 53.7% with a net profit margin of 8.4%. That is a strong return on shareholder capital.

What is the 52-week high and low of KIMIABIOSCIENCESLTD?

Kimia Biosciences Ltd (KIMIABIOSCIENCESLTD) has traded between ₹23.2 and ₹43.28 over the past 52 weeks.

Kimia Biosciences Ltd

₹0.00▲ +0.00 (+0.00%)

KIMIABIOSCIENCESLTD·NSE·Healthcare

Market Cap

135.39 Cr

PE Ratio

19.40

Volume

—

Day High - Low

—

52W High-Low

43.28 - 23.20

₹0.00▲ +0.00 (+0.00%)

Market Cap135.39 Cr

PE Ratio19.40

Volume—

Day High - Low—

52W High-Low43.28 - 23.20

Kimia Biosciences Ltd (KIMIABIOSCIENCESLTD): company summary

Kimia Biosciences Ltd (KIMIABIOSCIENCESLTD) is a micro-cap Healthcare company valued at ₹135 crore operating in Pharmaceuticals on the NSE and BSE.

Financial performance: Revenue has been shrinking at -3.8% a year over three years. Return on equity is 53.7%.
Valuation multiples: The stock trades at 19.4 times earnings, a discount to the Healthcare median of 32.0, 7.88 times book value.
Things to watch: Debt is 1.94 times equity.

Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Not a live price.

DocStoX Score

3.2/10

Poor

Fair Value

ROE

53.70%

Strong

P/E

19.40x

Fair

Debt / Equity

1.94

High

Industry

Healthcare

Pharmaceuticals

Overall View

Poor

Price performance

52W₹23.20

₹43.28

DocStoX take

Supported by quality (6.6), but held back by risk (0.7). Scored on 4 of 5 measures.

DocStoX score

Medium confidence

3.2

/10

Poor

Quality

Solid

ROE 53.7%

Valuation

Fair

P/E 19.4×

Growth

Slow

Revenue -2.9% 5Y CAGR

Risk

High risk

D/E 1.94

Momentum

No data

No technical indicators

Scored on 4 of 5 measures — the rest have no data for this company.

DocStoX research

Our verdict

Fairly Valued

Fair value not available

Current price

—

Upside / Downside

—

Implied CAGR

—

Priced in by the market

Uncertainty

—

Est. confidence

At a glance

Market Cap

₹135 Cr

52W High / Low

₹43 / ₹23

Dividend Yield

0.00%

Promoter Holding

74.94%

EPS (TTM)

₹2.03

Book Value

₹3.75

Key highlights

Strong returns on equity (54%)
Capital works hard — ROCE 42%
Revenue shrinking 3% a year
High leverage — debt is 1.9× equity

2 Positives4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Explore Kimia Biosciences Ltd’s valuation

Free deep-dive tools · no sign-up

Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.

Kimia Biosciences Ltd peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.

Sun Pharmaceutical Industries Limited Divi's Laboratories Limited Torrent Pharmaceuticals Limited Apollo Hospitals Enterprise Limited Zydus Lifesciences Limited Laurus Labs Limited Cipla Limited Dr. Reddy's Laboratories Limited Aurobindo Pharma Limited Mankind Pharma Limited Lupin Limited Manipal Health Enterprises Limited

Compare Kimia Biosciences Ltd with peers

Kimia Biosciences Ltd vs Sun Pharmaceutical Industries Limited Kimia Biosciences Ltd vs Divi's Laboratories Limited Kimia Biosciences Ltd vs Torrent Pharmaceuticals Limited Kimia Biosciences Ltd vs Apollo Hospitals Enterprise Limited Kimia Biosciences Ltd vs Zydus Lifesciences Limited Kimia Biosciences Ltd vs Laurus Labs Limited

Related tools & concepts

Value Kimia Biosciences Ltd with the ratios and calculators DocStoX uses in its analysis.

P/E RatioPrice to earnings Return on Equity (ROE)Profitability ROCECapital efficiency Debt to EquityLeverage P/B RatioPrice to book Net Profit MarginBottom-line efficiency DCF / Intrinsic ValueEstimate fair value CAGR CalculatorAnnualised return Dividend YieldIncome on price Position SizeRisk-based sizing Brokerage CalculatorCharges on a trade SIP CalculatorSystematic investing

Explore further

KIMIABIOSCIENCESLTD newsLatest coverage & filings Open screenerFilter the whole market